Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Traws Pharma's ebitda for the twelve months ending Jun 30, 2026 was -$21.40M. For fiscal 2025 it was -$17.81M. The highest annual figure on record is -$16.48M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.81M | – |
| FY2024 | Dec 31, 2024 | -$142.36M | – |
| FY2023 | Dec 31, 2023 | -$20.28M | – |
| FY2022 | Dec 31, 2022 | -$19.61M | – |
| FY2021 | Dec 31, 2021 | -$16.48M | – |
| FY2020 | Dec 31, 2020 | -$24.98M | – |
| FY2019 | Dec 31, 2019 | -$21.69M | – |
| FY2018 | Dec 31, 2018 | -$23.23M | – |
| FY2017 | Dec 31, 2017 | -$25.65M | – |
| FY2016 | Dec 31, 2016 | -$23.61M | – |
| FY2015 | Dec 31, 2015 | -$23.82M | – |
| FY2014 | Dec 31, 2014 | -$63.31M | – |
| FY2013 | Dec 31, 2013 | -$61.78M | – |
| FY2012 | Dec 31, 2012 | -$21.96M | – |
| FY2011 | Dec 31, 2011 | -$27.26M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$6.90M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.32M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.53M | – |
| Q2 FY2024 | Jun 30, 2024 | -$123.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.46M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.61M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.73M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.64M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.12M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.13M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.76M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.99M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.25M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.12M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.73M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.10M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.63M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.23M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.14M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.58M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.63M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.89M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.10M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.74M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.77M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.45M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.29M | – |
See a number that looks wrong?